portions of the vitreous that were attached to the retina contained fibrin adhesions and neutrophilic exudates.
Case Report
A 65-year-old man was referred to the orbital clinic with a 2-week history of blurred VISIon and bilateral proptosis. He had no previous significant medical history. His visual acuity was reduced to 6/36 in both eyes. There was 2 mm bilateral proptosis with inferior conjunctival chemosis. Slit lamp biomicroscopy revealed bilateral full thickness corneal crystals (Figs. I and 2). Fundal examin ation showed bilateral choroidal folds (Fig. 2) . Initial haematological investigations revealed anaemia (haem oglobin 10.9 g/dl) and an elevated erythrocyte sedimenta tion (30 mmlhour). A recent thyroid function test was normal. Biochemical investigations were performed including biochemical pro file, plasma protein and urine electrophoresis.
CT scans demonstrated bilateral soft tissue orbital masses. Both orbits had intraconal mass lesions which dis torted the posterior aspects of the globes and extended posteriorly along the optic nerves. After administration of intravenous contrast (iopamidol, 350 mg/ml, 50 ml intra venously) these masses enhanced significantly and were seen to infiltrate the posterior wall of the globe with asso ciated marked scleral thickening (Fig. 3) . There was in addition a separate extraconal mass in the upper outer LETTERS TO THE JOURNAL quadrant of the left orbit. The contiguous bone was intact. Magnetic resonance (MR) imaging was performed with intravenous gadolinium-DTPA. The lesions showed prominent enhancement and there was thickening and increased enhancement of the left lateral rectus muscle suggesting possible infiltration (Fig. 4 ). There were sev eral small enhancing areas within the diploic marrow spaces of the calvarium. A skull radiograph was per formed after the MR scan and demonstrated mUltiple lytic lesions within the calvarium (Fig. 5) .
A diagnosis of multiple myeloma with orbital involve ment and corneal crystallisation was made. This was con firmed by bone marrow biopsy, an IgG kappa paraproteinaemia (30.9 gil) and urinary Bence Jones proteins.
Treatment was initially orbital radiotherapy and dex amethasone (40 mg for 4 days) with a rapid decrease in proptosis. Systemic chemotherapy with vincristine (1.6 mg), doxorubicin (70 mg) and dexamethasone (40 mg for 4 days) was started 1 week after orbital radio therapy and repeated after 6 weeks. There was a rapid initial response but a relapse after 6 months has required further aggressive systemic chemotherapy and a guarded prognosis.
Discussion
Myeloma is a plasma cell neoplasm with a frequency in the order of 5 new cases per 100 000. ' Orbital involve ment is a rare finding and when it occurs it is, in the majority of cases, the initial presentation of the disease. In a review of the literature Rodman and Fone presented 30 cases in which 23 had unilateral proptosis as the initial Bilateral orbital involvement along with corneal crys tals in multiple myeloma has not been reported previously. Our patient also had conjunctival chemosis, which may be part of the infiltrative process. In a post-mortem study Benjamin et al.4 presented a case with disseminated multiple myeloma including orbital and conjunctival involvement.
Multiple myeloma and other dysproteinaemias must be considered in the differential diagnosis of corneal crys tallisation. 5 Francois and Rabaey,6 in a case of diffuse myelomatosis and penetrating keratoplasty for central corneal crystallisation, showed the possible relationship between the corneal crystallisation and paraproteinaemia. Klintworth et aC have subsequently performed detailed analysis of the nature of corneal crystals in a patient with multiple myeloma. Crystalline deposits were identified by light and electron microscopy in corneal material obtained at lamellar keratoplasty. By immunoperoxidase and immunofluorescent techniques the crystals reacted posi tively for immunoglobulin and particularly IgG kappa chains. It is proposed that crystals may occur in ocular tis sue either by an infiltration of plasma cells with crystalline inclusions or by spontaneous crystallisation of immu noglobulins. Penetrating keratoplasty should be deferred as they describe complete disappearance of corneal crys tals after 24 months of chemotherapy.
Multiple myeloma should be included in the differential diagnosis of both unilateral and bilateral proptosis of unknown cause. Although it usually presents in older patients in their sixth or seventh decades, a case presenting in a 19-year-old female has been described. 8 Systemic manifestations should be sought including bone pain, fatigue, anaemia, renal impairment, hypercalcaemia, amyloidosis, recurrent infections, bleeding, and both neurological and retinal changes secondary to hypervis cosity. The diagnosis triad in myeloma is osteolytic bone lesions, atypical plasma cells in the bone marrow and either the presence of a paraprotein on serum immuno electrophoresis and/or light chains in the urine. If surgery is being performed then care should be taken as acute renal failure may be precipitated.9 Dehydration is an important factor in the renal impairment and vigorous rehydration may improve renal function dramatically.
Patients with orbital and ocular involvement with multiple myeloma require radiotherapy and chemo therapy along with appropriate supportive measures. At the time of diagnosis of myeloma the abnormal clone may have been present for several years. The patient's disease often eventually escapes from control and death usually occurs as a result of infection, haemorrhage, hypervis cosity or renal disease.
